A study was conducted to compare indapamide with captopril in preventing the progress of diabetic nephropaty. Each group was consist of 25 NIDDM patients. The study showed that both drug were equaly effective in decreasing albumin exretion rate. Both drugs did not change lipid electrolit profile. It is concluded that indapamide could be used as an alternatif to captopril.